Adher Alsayed

520 total citations
19 papers, 304 citations indexed

About

Adher Alsayed is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Adher Alsayed has authored 19 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Adher Alsayed's work include Breast Cancer Treatment Studies (5 papers), Cancer Risks and Factors (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Adher Alsayed is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Risks and Factors (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Adher Alsayed collaborates with scholars based in Saudi Arabia, Egypt and Qatar. Adher Alsayed's co-authors include Taher Al‐Tweigeri, Dahish Ajarim, Asma Tulbah, Naser Elkum, Adnan Ezzat, Said Dermime, Ali S. Alzahrani, Mohamed Alshabanah, Huda H. Al‐Khalaf and Abdelilah Aboussekhra and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Scientific Reports.

In The Last Decade

Adher Alsayed

17 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adher Alsayed Saudi Arabia 10 173 111 58 55 39 19 304
Alison Lannigan United Kingdom 8 234 1.4× 106 1.0× 47 0.8× 53 1.0× 29 0.7× 21 325
Seyran Yiğit Türkiye 14 181 1.0× 93 0.8× 62 1.1× 76 1.4× 25 0.6× 43 433
Laura Iezzi Italy 11 308 1.8× 102 0.9× 84 1.4× 76 1.4× 22 0.6× 21 411
Valentina Zanfagnin United States 12 182 1.1× 54 0.5× 47 0.8× 76 1.4× 22 0.6× 24 470
Deirdre Kelly Canada 10 165 1.0× 107 1.0× 89 1.5× 87 1.6× 23 0.6× 30 362
Nicole E. James United States 12 91 0.5× 81 0.7× 71 1.2× 75 1.4× 19 0.5× 32 298
Rita Mágenheim United States 6 105 0.6× 71 0.6× 58 1.0× 104 1.9× 15 0.4× 10 345
Ying‐Yang Liao China 11 99 0.6× 141 1.3× 23 0.4× 73 1.3× 53 1.4× 15 308
Nikoletta Sidiropoulos United States 8 163 0.9× 135 1.2× 34 0.6× 76 1.4× 29 0.7× 21 336
Piera Gargiulo Italy 10 204 1.2× 101 0.9× 43 0.7× 97 1.8× 14 0.4× 26 393

Countries citing papers authored by Adher Alsayed

Since Specialization
Citations

This map shows the geographic impact of Adher Alsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adher Alsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adher Alsayed more than expected).

Fields of papers citing papers by Adher Alsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adher Alsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adher Alsayed. The network helps show where Adher Alsayed may publish in the future.

Co-authorship network of co-authors of Adher Alsayed

This figure shows the co-authorship network connecting the top 25 collaborators of Adher Alsayed. A scholar is included among the top collaborators of Adher Alsayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adher Alsayed. Adher Alsayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Alsayed, Adher, et al.. (2025). Lymphoepithelioma-Like Carcinoma of the Urinary Bladder: A Case Report. Cureus. 17(6). e86220–e86220.
2.
Elhassan, Tusneem, et al.. (2024). Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer. Oncology Letters. 28(3). 429–429. 1 indexed citations
3.
Elhassan, Tusneem, et al.. (2022). Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia. International Journal of Women s Health. Volume 14. 373–384. 7 indexed citations
4.
Ghebeh, Hazem, et al.. (2022). Peripheral Blood Eosinophil Count is Associated with Response to Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer. Immunotherapy. 14(4). 189–199. 23 indexed citations
5.
Ghebeh, Hazem, Adher Alsayed, Riham Eiada, et al.. (2021). Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer. Scientific Reports. 11(1). 19154–19154. 18 indexed citations
6.
Elhassan, Tusneem, et al.. (2021). Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer. Cancer Management and Research. Volume 13. 9411–9420. 1 indexed citations
7.
Alsayed, Adher, et al.. (2021). Metaplastic breast cancer: Disease characteristics and outcome in Arab women.. Journal of Clinical Oncology. 39(15_suppl). e12534–e12534.
8.
Ajarim, Dahish, et al.. (2020). Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs. Breast Care. 16(1). 59–65. 1 indexed citations
9.
Almalik, Osama, Adher Alsayed, Dahish Ajarim, et al.. (2020). Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?. Oncology. 98(3). 168–173. 23 indexed citations
10.
Al‐Tweigeri, Taher, et al.. (2020). Association between obesity and the clinical stage of newly diagnosed breast cancer: Experience with 2212 patients.. Journal of Clinical Oncology. 38(15_suppl). e12602–e12602. 4 indexed citations
11.
12.
Al‐Khalaf, Huda H., Adher Alsayed, Maria Arafah, et al.. (2018). Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects. Molecular and Cellular Biology. 39(2). 44 indexed citations
13.
Al‐Khalaf, Huda H., et al.. (2017). Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Molecular and Cellular Biology. 37(17). 13 indexed citations
14.
15.
Owaidah, Tarek, Saad Alghamdi, Dania Alkhafaji, et al.. (2014). Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents. Thrombosis Journal. 12(1). 28–28. 15 indexed citations
16.
Alkhenizan, Abdullah, Aneela Hussain, & Adher Alsayed. (2013). The sensitivity and specificity of screening mammography in primary care setting in Saudi Arabia.. Journal of Clinical Oncology. 31(15_suppl). e12551–e12551. 3 indexed citations
17.
Gaafar, Ameera, Mahmoud Aljurf, Pulicat Manogaran, et al.. (2009). Defective γδ T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. Experimental Hematology. 37(7). 838–848. 38 indexed citations
18.
Elkum, Naser, Said Dermime, Dahish Ajarim, et al.. (2007). Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience. BMC Cancer. 7(1). 222–222. 88 indexed citations
19.
Ezzat, Adnan, Ezzeldin M. Ibrahim, Robert K. Stuart, et al.. (2000). Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial. Medical Oncology. 17(1). 39–46. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alison Lannigan Breakdown of academic impact, for papers by Seyran Yiğit Breakdown of academic impact, for papers by Laura Iezzi Breakdown of academic impact, for papers by Valentina Zanfagnin Breakdown of academic impact, for papers by Deirdre Kelly Breakdown of academic impact, for papers by Nicole E. James Breakdown of academic impact, for papers by Rita Mágenheim Breakdown of academic impact, for papers by Ying‐Yang Liao Breakdown of academic impact, for papers by Nikoletta Sidiropoulos Breakdown of academic impact, for papers by Piera Gargiulo
Rankless by CCL
2026